AUSTIN, Texas (PRWEB) March 17, 2021
Benchmark Research has been recognized as one among the elite group of companies that are featured in the 2021 eClinical Trial Management edition of Pharma Tech Outlook magazine.
“We are glad to announce Benchmark Research as one of the Top 10 eClinical Trial Management Consulting/Service Companies – 2021,” said Stacey Smith, Editor-in-Chief of Pharma Tech Outlook. “This recognition is a testament to Benchmark Research’s expertise in conducting investigational studies for the development of new vaccines and medicines to help prevent a wide range of illnesses.”
Benchmark Research’s superior team of motivated and focused investigators have clinical trials experience in a wide range of therapeutic areas such as acute care, allergy, general medicine, obesity, smoking cessation, vaccines, and women’s health. The firm’s knowledgeable investigators, who are highly trained in GCP and FDA regulations, enthusiastically embrace clinical research and the opportunities that new therapies bring to the marketplace and patients.
Benchmark Research was founded in 1997 by Mark Lacy and Scott Barrett, who currently serve as the firm’s CEO and president, respectively. Over the years, the firm has developed a track record of safety and expertise, having conducted more than 1,000 trials with 40,000+ participants. Benchmark Research works in partnership with the private and public sectors at clinics located in California, Louisiana, and Texas to ensure consumers receive safe and effective medications and vaccines. For more information, visit: http://www.benchmarkresearch.net
Pharma Tech Outlook is a pioneer in bringing forth real world solutions, news, product trends, solutions and many more to its subscribers. The magazine’s unique learn-from-peers approach is creating a difference since the decision-makers are constantly sharing their experience, wisdom and thought leadership with each other. Pharma Tech Outlook brings forth a clear insight into the design, development, manufacture, evaluation and dosage of drug delivery system, including breakthroughs in pharmaceutical infrastructure, tools, and equipment. Covering all the novel outcomes, the magazine aims at contributing to the transformation of innovations into services as well as creating a healthy and productive ecosystem. For more info, visit: http://www.pharmatechoutlook.com